Jacobson Pharma Corporation Ltd banner
J

Jacobson Pharma Corporation Ltd
HKEX:2633

Watchlist Manager
Jacobson Pharma Corporation Ltd
HKEX:2633
Watchlist
Price: 1.1 HKD -0.9% Market Closed
Market Cap: HK$2.2B

Wall St Price Targets

Price Targets Summary
Jacobson Pharma Corporation Ltd

Wall Street analysts forecast Jacobson Pharma Corporation Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Jacobson Pharma Corporation Ltd is 2.5 HKD with a low forecast of 2.47 HKD and a high forecast of 2.57 HKD.

Lowest Forecast
Price Target
2.47 HKD
125% Upside
Average Forecast
Price Target
2.5 HKD
127% Upside
Highest Forecast
Price Target
2.57 HKD
134% Upside
Jacobson Pharma Corporation Ltd Competitors:
Price Targets
AMBR
Amber International Holding Ltd
510% Upside

Revenue
Forecast

5% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
5% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 10 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 4%.

Gross Profit
Forecast

6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Jacobson Pharma Corporation Ltd

Operating Income
Forecast

12% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
12% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 10 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 2%.

Pre-Tax Income
Forecast

11% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
11% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Jacobson Pharma Corporation Ltd

Net Income
Forecast

11% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
11% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Over the last 10 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 5%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Jacobson Pharma Corporation Ltd's stock price target?
Price Target
2.5 HKD

According to Wall Street analysts, the average 1-year price target for Jacobson Pharma Corporation Ltd is 2.5 HKD with a low forecast of 2.47 HKD and a high forecast of 2.57 HKD.

What is the Revenue forecast for Jacobson Pharma Corporation Ltd?
Projected CAGR
4%

Over the last 10 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 4%.

What is the Operating Income forecast for Jacobson Pharma Corporation Ltd?
Projected CAGR
2%

Over the last 10 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 2%.

What is the Net Income forecast for Jacobson Pharma Corporation Ltd?
Projected CAGR
5%

Over the last 10 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 5%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett